Current Neuropharmacology
Volume 19, 12 Issues, 2021
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
Contents
Current Neuropharmacology, Volume 14 - Number 3
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand?
, 14(3): 214 - 225Jean-Marc Taymans and Elisa Greggio
DOI: 10.2174/1570159X13666151030102847
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand?
Modulating the Amyloidogenesis of α-Synuclein
, 14(3): 226 - 237Kalkena Sivanesam and Niels H. Andersen
DOI: 10.2174/1570159X13666151030103153
Modulating the Amyloidogenesis of α-Synuclein
Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson´s Disease
, 14(3): 238 - 249Pilar Rivero-Ríos, Jesús Madero-Pérez,, Belén Fernández and Sabine Hilfiker
DOI: 10.2174/1570159X13666151030103027
Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson´s Disease
Counteracting PINK/Parkin Deficiency in the Activation of Mitophagy: A Potential Therapeutic Intervention for Parkinson’s Disease
, 14(3): 250 - 259Alice Nardin, Emilie Schrepfer and Elena Ziviani
DOI: 10.2174/1570159X13666151030104414
Counteracting PINK/Parkin Deficiency in the Activation of Mitophagy: A Potential Therapeutic Intervention for Parkinson’s Disease
Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View
, 14(3): 260 - 271Roberta Filograna, Mariano Beltramini, Luigi Bubacco and Marco Bisaglia
DOI: 10.2174/1570159X13666151030102718
Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View
Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis
, 14(3): 272 - 281Chi-Hsien Huang, Chia-Chen Huang, Cheuk-Kwan Sun, Gong-Hong Lin and Wen-Hsuan Hou
DOI: 10.2174/1570159X13666150514233033
Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis
Selenium in the Therapy of Neurological Diseases. Where is it Going?
, 14(3): 282 - 299Agnieszka Dominiak, Anna Wilkaniec, Piotr Wroczyński and Agata Adamczyk
DOI: 10.2174/1570159X14666151223100011
Selenium in the Therapy of Neurological Diseases. Where is it Going?
Editor-in-Chief
Ferdinando Nicoletti
University Rome"da Sapienza"
Rome
(Italy)
University Rome"da Sapienza"
Rome
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net